参考文献/References:
[1] 薛佩妮,冯敏娟,王惠琴.噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响[J].陕西医学杂志,2020,49(2):216-219.
[2] 申永春,文富强.2017年慢性阻塞性肺疾病全球创议更新解读[J].中国实用内科杂志,2017,37(2):132-135.
[3] 李 蒙,张培彤,郭秀伟.中医证候分级量化诊断标准的研究进展[J].中华中医药杂志,2017,32(8):3641-3643.
[4] 张慧俭,刘世举.益气活血补肾汤治疗慢性阻塞性肺疾病合并肺动脉高压气虚证[J].中医学报,2019,4(12):2635-2640.
[5] 杨栓柱,王 文,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2019,40(5):600-603.
[6] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志:电子版,2014,36(2):255-264.
[7] 李建生,张海龙,王海峰,等.慢性阻塞性肺疾病证候演变特点临床调查[J].中医杂志,2017,58(9):772-776.
[8] Zhang HL,Tan M,Qiu AM,et al.Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease:a network meta-analysis[J].BMC Pulm Med,2017,17(1):196.
[9] 郑燕冰,刘玉华.经鼻面罩呼吸机联合纳洛酮治疗慢性阻塞性肺病并肺性脑病的疗效分析[J].中国急救复苏与灾害医学杂志,2019,14(4):398-400.
[10] 张玉龙.平肺化瘀汤联合阿司匹林对COPD合并继发性红细胞增多症患者凝血功能、呼吸功能和运动耐量的影响[J].陕西中医,2018,39(1):53-55.
[11] 冯秀莉,曹延伦,任欣欣,等.益气润肺汤联合黄芪注射液对耐药肺结核患者临床症状及机体免疫功能影响[J].世界中西医结合杂志,2019,14(10):1423-1426.
[12] 杨添文,李梅华,任朝凤,等.疏风解毒胶囊对慢性阻塞性肺疾病急性加重期患者炎症因子的影响及安全性评价[J].中国中医急症,2019,28(10):1824-1827.
[13] 黄明儒,杨玉萍,许忠波,等.稳定期慢性阻塞性肺疾病的中医分型论治研究进展[J].江西中医药大学学报,2019,31(5):113-116.
[14] 唐卓然,吴海斌,李勇铭,等.益气消癥通络方对慢性阻塞性肺疾病血管重塑模型大鼠VEGF、ET-1和CTGF表达的影响[J].中华中医药学刊,2019,37(5):1137-1140.
[15] Wang C,Chen X,Du L,et al.Comparison of machine learning algorithms for the identification of acute exacerbations in chronic obstructive pulmonary disease[J].Comput Methods Programs Biomed,2019,188(1):105267.
[16] 李缙婷,王 琦,吴海斌,等.益气消癥通络方治疗慢性阻塞性肺疾病稳定期疗效观察[J].中华中医药杂志,2018,33(6):2699-2701.
[17] Liu BH,Sun MX,Zhou N,et al.Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease[J].J Biol Regul Homeost Agents,2016,30(3):839-845.
[18] Dong J,Li Z,Luo L,et al.Efficacy of pulmonary rehabilitation in improving the quality of life for patients with chronic obstructive pulmonary disease:evidence based on nineteen randomized controlled trials-a systematic review and meta-analysis[J].Int J Surg,2019,12(4):145-147.
[19] 金忠富,何小花,王玲霞.噻托溴铵吸入剂联合沙美特罗替卡松粉吸入剂对中重度慢性阻塞性肺疾病患者稳定期的肺功能及预后的影响[J].中国临床药理学杂志,2017,33(12):1075-1078.
[20] 曾林淼,俞晓莲,叶凯龙,等.沙美特罗替卡松联合噻托溴铵与单用沙美特罗替卡松治疗我国慢性阻塞性肺疾病患者的Meta分析[J].中国呼吸与危重监护杂志,2017,16(6):545-554.
相似文献/References:
[1]杨艳菁,蒋 玲△,李 霞.益气通络消癥汤对慢性阻塞性肺疾病患者肺功能及血清sICAM-1、MMP-9水平的影响*[J].陕西中医,2020,(9):1225.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.013]
[2]陈辅萍,彭 琦△.肺力咳胶囊联合沙丁胺醇治疗慢性阻塞性肺疾病疗效及对患者肺功能的影响[J].陕西中医,2020,(9):1228.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
CHEN Fuping,PENG Qi..Effect of Feilike capsule combined with salbutamol on chronic obstructive pulmonary disease and pulmonary function[J].,2020,(7):1228.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
[3]吴 爽,王宏君,陈 琛,等.通腑益气平喘汤联合西药对慢性阻塞性肺疾病急性发作合并呼吸衰竭患者血气状态及机体微炎症反应的影响*[J].陕西中医,2020,(12):1735.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.014]
[4]翟豫疆,苏 军,梁丽丽,等.滋阴利肺汤治疗肺结核合并慢性阻塞性肺疾病疗效及对患者肺泡巨噬细胞分泌细胞因子水平的影响[J].陕西中医,2021,(8):1041.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
ZHAI Yujiang,SU Jun,LIANG Lili,et al.Effect of Ziyin Lifei decoction in the auxiliary treatment of pulmonary tuberculosis patients with chronic obstructive pulmonary disease and its effect on the secretion of cytokines by alveolar macrophages[J].,2021,(7):1041.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
[5]李竹英,陈 璐,王丽洁.麻黄-白果药对“异病同治”支气管哮喘和慢性阻塞性肺疾病药理作用研究[J].陕西中医,2021,(8):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
LI Zhuying,CHEN Lu,WANG Lijie.Pharmacological mechanism of Ephedra and Ginkgo couplet medicine in treating asthma and COPD based on treating different diseases with the same treatment[J].,2021,(7):1128.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
[6]孙境孺,李竹英.NF-κB信号通路在肺部疾病中的作用研究进展及中医药干预现状[J].陕西中医,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
SUN Jingru,LI Zhuying.Research progress of role of NF-κB signaling pathway in lung diseases and the current situation of traditional Chinese medicine intervention[J].,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]